Marek's disease virus latency

Current Topics in Microbiology and Immunology

Volumn 255, Issue , 2000, Pages 223-243

  Morgan, R W ^a   Xie, Q ^a   Cantello, J L ^a   Miles, A M ^a   Bernberg, E L ^a   Kent, J ^a   Anderson, A ^a  

^a UNIVERSITY OF DELAWARE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; PHOSPHOPROTEIN; PHOSPHOPROTEIN PP24; PHOSPHOPROTEIN PP38; PROTEIN MEQ; UNCLASSIFIED DRUG; VIRUS DNA; VIRUS PROTEIN;

AVIAN LYMPHOMATOSIS HERPETOVIRUS; LYMPHOBLASTOID CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; VIRUS EXPRESSION; VIRUS GENOME; VIRUS LATENCY; VIRUS TRANSCRIPTION;

ANIMALS; CELL LINE; CHICKENS; GENOME, VIRAL; HERPESVIRUS 2, GALLID; MUTATION; PROMOTER REGIONS (GENETICS); TRANSCRIPTION, GENETIC; TUMOR VIRUS INFECTIONS; VIRAL PROTEINS; VIRUS LATENCY;

ANIMALIA; AVES; DNA VIRUSES; GALLID HERPESVIRUS 2; GALLUS GALLUS; HERPETOVIRUS; MARDIVIRUS;

EID: 0034531928     PISSN: 0070217X     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Review

References (105)

1. Development of a sustainable chick cell line system infected with Marek's disease virus
2. Marek's disease virus (MDV) genomes are stabilized and in a latent state within MDV OU2 cells
3. Evidence that Marek's disease virus exists in a latent state in a sustainable fibroblast cell line
4. Development of a cell line system susceptible to infection with vaccine strains of MDV
5. Complete nucleotide sequence of the Marek's disease virus IPC4 gene
6. Regulation and cell-type-specific activity of a promoter located upstream of the latency-associated transcript of herpes simplex virus type 1
7. Open reading frames in a 4556 nucleotide sequence within MDV-1 BamHI-D DNA fragment: Evidence for splicing of mRNA from a new viral glycoprotein gene
8. Structure of the Marek's disease virus BamHI-H gene family: Genes of putative importance for tumor induction
9. Loss of Marek's disease virus tumorigenicity is associated with truncation of RNAs transcribed within BamHI-H
10. Functional analysis of the MDV basic-leucine zipper product, Meq
11. Maintenance of Marek's disease herpesvirus latency in vitro by a factor found in conditioned medium
12. Effect of immunocompetence on the establishment and maintenance of latency with Marek's disease herpesvirus
13. Marek's disease
14. Latent infections with Marek's disease virus and turkey herpesvirus
15. Spontaneous and induced herpesvirus genome expression in Marek's disease tumor cell lines
16. Further characterization of Marek's disease virus-infected lymphocytes. 1. In vivo infection
17. Identification of latency-associated transcripts that map antisense to the ICP4 homolog gene of Marek's disease virus
18. Marek's disease virus latency-associated transcripts belong to a family of spliced RNAs that are antisense to the ICP4 homolog gene
19. Multiple bi-directional initiations and terminations of transcription in the Marek's disease virus long repeat regions
20. Identification of a unique Marek's disease virus gene which encodes a 38-kilodalton phosphoprotein and is expressed in both lytically infected cells and latently infected lymphoblastoid tumor cells
21. Marek's disease virus gene clones encoding virus-specific phosphorylated polypeptides and serological characterization of fusion proteins
22. Structural analysis and transcriptional mapping of the Marek's disease virus gene encoding pp38, an antigen associated with transformed cells
23. Expression and processing of Marek's disease virus pp38 gene in insect cells and immunological characterization of the gene product
24. Status of Marek's disease virus in established lymphoma cell lines: Herpesvirus integration is common
25. Latent Marek's disease virus can be activated from its chromosomally integrated state in herpesvirus-transformed lymphoma cells
26. Establishment of a lymphoblastoid cell line using a mutant MDV containing a green fluorescent protein expression cassette
27. Induction of Marek's disease virus antigens by IdUrd in a chicken lymphoblastoid cell line
28. Association of the herpes simplex virus regulatory protein ICP4 with specific nucleotide sequences
29. The molecular biology of herpes simplex virus latency
30. The latency-associated transcripts of herpes simplex virus: RNA in search of function
31. The structure of Marek disease virus DNA: The presence of unique expansion in nonpathogenic viral DNA
32. Latency and reactivation of Marek's disease virus in B lymphocytes transformed by avian leucosis virus
33. The molecular basis of latency in pathogenic human viruses
34. A novel latency-active promoter is contained within the herpes simplex virus type 1 UL flanking repeats
35. Isolation of serotype 2 Marek's disease virus from a cell line of avian lymphoid leucosis
36. RNA transcribed from Marek's disease virus genomes in productively and latently infected cells
37. Tissue-specific restriction of latent turkey HVT transcription
38. A comparative study of histological conditions suitable for both immunofluorescence and in situ hybridization in the detection of herpesvirus and its antigens in tissues of chickens
39. Latent turkey herpesvirus infection in lymphoid, nervous, and feather tissues of chickens
40. Identification of an immediate-early gene in the Marek's disease virus long internal repeat region which encodes a unique 14-kilodalton polypeptide
41. A 14-kDa immediate-early phosphoprotein is specifically expressed in cells infected with oncogenic Marek's disease virus strains and their attenuated derivatives
42. Sequence determination of cDNA clones of transcripts from the tumor-associated region of the Marek's disease virus genome
43. A heat-shock-like sequence in the meq gene promoter binds a factor in MDV lymphoblastoid cells
44. Marek's disease virus encodes a leucine zipper gene resembling the fos/jun family of oncogenes that is highly expressed in lymphoblastoid tumors
45. Intracellular state of Marek's disease virus DNA in two tumour-derived chicken cell lines
46. Maf nuclear oncoprotein recognizes sequences related to an AP-1 site and forms heterodimers with both Fos and Jun
47. The inhibitory effect of oligonucleotides complementary to Marek's disease virus mRNA transcribed from the BamHI-H region, on the proliferation of transformed lymphoblastoid cells, MDCC-MSB1
48. A conserved region adjacent to the basic domain is required for recognition of an extended DNA binding site by Maf/Nr1 family proteins
49. The 132bp repeats are present in RNA transcripts from 1.8kb gene family of Marek disease virus-transformed cells
50. Host cell proteins bind to the cis-acting site required for virion-mediated induction of herpes simplex virus type 1 α genes
51. The regulation of synthesis and properties of the protein product of open reading frame P of the herpes simplex virus 1 genome
52. Identification of novel transcripts complementary to the Marek's disease virus homologue of the ICP4 gene of herpes simplex virus
53. Further characterization of the latency-associated transcription unit of Marek's disease virus
54. Nucleolar and nuclear localization properties of a herpesvirus bZIP oncoprotein MEQ
55. Transforming potential of herpesvirus oncoprotein MEQ: Morphological transformation, serum-independent growth, and inhibition of apoptosis
56. Meq and v-IL8: Cellular genes in disguise?
57. Functional interactions between herpesvirus oncoprotein Meq and cell cycle regulator CDK2
58. Mapping of Marek's disease virus genome: Identification of junction sequences between unique and inverted repeat regions
59. Amplification of a tandem direct repeat within inverted repeats of Marek's disease virus DNA during serial in vitro passage
60. RNA transcripts of Marek's disease virus (MDV) serotype-1 in infected and transformed cells
61. The transcripts from the sequences flanking the short component of Marek's disease virus during latent infection form a unique family of 3' coterminal RNAs
62. The Marek's disease virus ICP4 gene: Update on sense and antisense RNAs and characterization of the gene product
63. An updated list of avian cell lines and transplantable tumours
64. Deoxyribonucleic acid of Marek's disease virus in a lymphoblastoid cell line from Marek's disease tumours
65. Establishment and characterization of a virus-free chick cell line
66. Characterization of Marek's disease virus BamHI-A-specific cDNA clones obtained from a Marek's disease lymphoblastoid cell line
67. Characterization of a Marek's disease virus BamHI-L-specific cDNA clone obtained from a Marek's disease lymphoblastoid cell line
68. Nucleotide sequence analysis of Marek's disease virus (MDV) serotype 2 homolog of MDV serotype 2 pp38, an antigen associated with transformed cells
69. Characterization of Marek's disease virus insertion and deletion mutants that lack US1 (ICP22 homolog), US10, and/or US2 and neighboring short-component open reading frames
70. Characterization of a Marek's disease virus mutant containing a lacZ insertion in the US6 (gD) homologue gent
71. Retention of oncogenicity by a Marek's disease virus (MDV) mutant lacking six unique-short region genes
72. Recombinant Marek's disease virus (MDV)-derived lymphoblastoid cell lines: Regulation of a marker gene within the context of the MDV genome
73. Isolation and characterization of cDNAs from BamHI-H gene family RNAs associated with the tumorigenicity of Marek's disease virus
74. Prolonged proliferation of primary chicken embryo fibroblasts transfected with cDNAs from the BamHI-H gene family of Marek's disease virus
75. A 7 kDa protein encoded by the BamHI-H gene family of Marek's disease virus is produced in lytically and latently infected cells
76. Isolation and characterization of Marek's disease virus (MDV) cDNAs mapping to the BamHI-I2, BamHI-Q2, and BamHI-L fragments of the MDV genome from lymphoblastoid cells transformed and persistently infected with MDV
77. Characterization of the protein product encoded by a splicing variant of the Marek's disease virus Eco-Q gone (Meq)
78. Isolation and characterization of Marek's disease virus (MDV) cDNAs from a MDV-transformed lymphoblastoid cell line: Identification of an open reading frame antisense to the MDV Eco-Q protein (Meq)
79. Enhanced expression of the Marek's disease virus-specific phosphoproteins after stable transfection of MSB-1 cells with the Marek's disease virus homolog of ICP4
80. Transactivation activity of meq, a Marek's disease herpesvirus bZIP protein persistently expressed in latently infected transformed T cells
81. Novel DNA binding specificities of a putative herpesvirus bZIP oncoprotein
82. Molecular biology of the virus
83. Persistence and expression of Marek's disease virus DNA in tumour cells and peripheral nerves studied by in situ hybridization
84. Expression of MDV genes in lymphomas and their role in oncogenesis
85. Marek's disease virus EcoRI-Q gene (meq) and a small RNA antisense to ICP4 are abundantly expressed in CD4+ cells and cells carrying a novel lymphoid marker, AV37, in Marek's disease lymphomas
86. Partial transcription map of Marek's disease herpesvirus in lytically infected cells and lymphoblastoid cell lines
87. Open reading frame L1 of Marek's disease herpesvirus is not essential for in vitro and in vivo virus replication and establishment of latency
88. The bi-directional transcriptional promoters for the latency-relating transcripts of the pp38/pp24 mRNAs and the 118 kb-mRNA in the long inverted repeats of Marek's disease virus serotype 1 DNA are regulated by common promoter-specific enhancers
89. Differentiation of pathogenic and non-pathogenic serotype 1 Marek's disease viruses (MDVs) by the polymerase chain reaction amplification of the tandem direct repeats within the MDV genome
90. Genomie expansion of Marek's disease virus DNA is associated with serial in vitro passage
91. Transcription of the Marek's disease virus genome in a nonproductive chicken lymphoblastoid cell line
92. Human herpesviruses: A consideration of the latent state
93. Latent transcripts of Marek's disease virus are clustered in the short and long repeat regions
94. Biochemical evidence of the non-integrated status of Marek's disease virus DNA in virus-transformed lymphoblastoid cells of chickens
95. Accumulation of viral transcripts coding for a DNA binding protein in Marek's disease tumor cells
96. Cytokine modulation of latency in Marek's disease virus-infected cells
97. Stages of Marek's disease virus latency defined by variable sensitivity to interferon modulation of viral antigen expression
98. Herpesvirus transcription - General aspects
99. Identification of Marek's disease virus nuclear antigen in latently infected lymphoblastoid cells
100. Marek's disease virus (MDV) ICP4, pp38, and meq genes are involved in the maintenance of transformation of MDCC-MSBI MDV-transformed lymphoblastoid cells
101. Differentiation of oncogenic and nononcogenic strains of Marek's disease virus type 1 by using polymerase chain reaction DNA amplification
102. Marek's disease virus type 1-specific phosphorylated proteins pp38 and pp24 with common amino acid termini are encoded from the opposite junction regions between the long unique and inverted repeat sequences of viral genomes
103. Activity of herpes simplex virus type 1 latency associated transcript (LAT) promoter in neuron derived cells: Evidence for neuron specificity and for a large LAT transcript
104. Identification of a major regulatory sequence in the latency associated transcript (LAT) promoter of herpes simplex virus type 1 (HSV-1)